FEMY
FEMASYS INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$1.63
−1.21%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.73
From 52W high−92.16%
Volume93633.00
Market cap$13.65M
P/E (TTM)—
P/S (TTM)5.9x
Div yield—
Key dataOct 19, 2026
Open
$1.73
From 52W high
−92.16%
Volume
93633.00
Market cap
$13.65M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.8x
P/E (TTM)
—
RSI (14)
31.9
MomentumView details →
1D Return
−1.21%
YTD Return
−85.50%
SummaryUpdated Jun 1, 2026
Femasys Inc. (NASDAQ:FEMY) is a biomedical company founded in 2004 and headquartered in Suwanee, Georgia, that specializes in developing and commercializing medical devices for women's healthcare. The company went public in June 2021 and focuses on creating innovative solutions for reproductive health, including permanent birth control, fertility treatments, and diagnostic procedures. Femasys operates in the medical devices sector, specifically targeting the underserved women's healthcare market with proprietary technologies designed to provide minimally invasive alternatives to traditional surgical procedures.
Similar companies
Latest newsMore news →
FEMASYS INC doubled the number of enrolling sites in its FemBloc FINALE pivotal trial to 12 academic and private clinical sites across the United States.6d agoFemasys Inc. announced that Minnesota Women's Care will implement FemVue for fertility diagnostic evaluation and FemaSeed Complete for in-office first-line fertility treatment across its four OB/GYN practice locations.35d agoFemasys Inc. announced a partnership with CapexMD to expand patient access to its FemaSeed fertility portfolio through dedicated financing solutions.41d ago